OPTICAL IMAGING AND BIOSENSING

RESEARCH TOPICS

Amos

DR. AMOS DANIELLI

Dr. Danielli specializes in Electro-optics and Bio-photonics. After completing his Bachelor’s and Master’s degrees in the field of optical communication at Tel Aviv University, he worked in industry for eight years and then return to the Academy. During his studies for P.hD, he developed a new technology to rapidly detect fluorescent-labeled probes at very low concentrations in homogenous solutions and continued developing it during his post-doctoral studies in Washington University, St. Louis.

In 2014, he has returned to Israel and joined the faculty of Engineering at Bar Ilan University.

During his stay in the US, he founded a company that commercializes this technology, and established connections with key figures in the fields of medical laboratory and diagnostics, and especially among troponin and heart attack specialists.

October 2021

An interview with the head of the Optical Imaging and Biosensing Laboratory at Bar Ilan University, Dr. Amos Danielli, in the israeli channel, "Channel 13", on the the first israeli pilot to examine the validity of swab-free, saliva-based PCR tests. The PCR test was developed in our lab, with funding and support from Healthcare Israel and the Administration for the Development of Technological Infrastructure of the Ministry of Defense. It involves saliva testing (instead of a swab) and shortens the time it takes to receive results to 45 minutes, rather than a number of hours. Data and sensitivity efficacy, following trials conducted under laboratory conditions and using devices developed by Magbiosense, the company commercializing the technology, has yielded performance levels similar to those of a standard PCR test with a swab, the standard test administered in the State of Israel and around the world. 

Watch the following video:

An interview with the head of the Optical Imaging and Biosensing Laboratory at Bar Ilan University, Dr. Amos Danielli, in the israeli channel, "Channel 13", on the the first israeli pilot to examine the validity of swab-free, saliva-based PCR tests. The PCR test was developed in our lab, with funding and support from Healthcare Israel and the Administration for the Development of Technological Infrastructure of the Ministry of Defense. It involves saliva testing (instead of a swab) and shortens the time it takes to receive results to 45 minutes, rather than a number of hours. Data and sensitivity efficacy, following trials conducted under laboratory conditions and using devices developed by Magbiosense, the company commercializing the technology, has yielded performance levels similar to those of a standard PCR test with a swab, the standard test administered in the State of Israel and around the world.

Watch the following video:

More news 

October 2021

On October 7, the israeli channel, "Channel 12", broadcasted an article on the first israeli pilot to examine the validity of swab-free, saliva-based PCR tests. The test and the detection technologies were developed in the Optical Imaging and Biosensing Laboratory at Bar Ilan University and commercialized as a point of care device by Magbiosense Inc.

Watch the following video from 13:45 minutes:

On October 7, the israeli channel, "Channel 12", broadcasted an article on the first israeli pilot to examine the validity of swab-free, saliva-based PCR tests. The test and the detection technologies were developed in the Optical Imaging and Biosensing Laboratory at Bar Ilan University and commercialized as a point of care device by Magbiosense Inc.

Watch the following video from 13:45 minutes:

More news 

Thanks for your interest

We are always happy to hear from postdocs and students at all levels (BSc., MSc. and PhD.) with various backgrounds (mathematics, engineering, physics, biology) who are interested by the kind of research we are doing. send an email to Amos.danielli2@gmail.com

Website design and development: WebMeUp